US7517884B2
(en)
|
1998-03-30 |
2009-04-14 |
Kalypsys Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
TWI263497B
(en)
*
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
TW200526626A
(en)
|
2003-09-13 |
2005-08-16 |
Astrazeneca Ab |
Chemical compounds
|
GB0325956D0
(en)
*
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7745630B2
(en)
*
|
2003-12-22 |
2010-06-29 |
Justin Stephen Bryans |
Triazolyl piperidine arginine vasopressin receptor modulators
|
JP4958560B2
(ja)
*
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Gpcr受容体作動薬としてのヘテロ環誘導体
|
EP1716143A1
(de)
*
|
2004-02-18 |
2006-11-02 |
AstraZeneca AB |
Polyheterocyclische verbindungen und deren verwendung als antagonisten des metabotropen glutamatrezeptors
|
US7269708B2
(en)
*
|
2004-04-20 |
2007-09-11 |
Rambus Inc. |
Memory controller for non-homogenous memory system
|
US8071624B2
(en)
|
2004-06-24 |
2011-12-06 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
MX2007001540A
(es)
*
|
2004-08-10 |
2007-04-23 |
Incyte Corp |
Compuestos amido y sus usos como farmaceuticos.
|
CA2580845A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
TW200626138A
(en)
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
BRPI0515505A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
|
EP1799664A1
(de)
|
2004-09-20 |
2007-06-27 |
Xenon Pharmaceuticals Inc. |
Heterozyklische derivate und ihre verwendung als stearoyl-coa-desaturase-inhibitoren
|
CA2580857A1
(en)
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
EP1799668A1
(de)
|
2004-09-20 |
2007-06-27 |
Xenon Pharmaceuticals Inc. |
Heterozyklische derivate und ihre verwendung als stearoyl-coa-desaturase-mediatoren
|
TW200630337A
(en)
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
MX2007005205A
(es)
|
2004-10-29 |
2007-05-11 |
Kalypsys Inc |
Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma.
|
PL2607362T3
(pl)
*
|
2005-02-17 |
2015-05-29 |
Astellas Pharma Inc |
Karboksylany piperydyny i piperazyny jako inhibitory FAAH
|
CN101163693B
(zh)
|
2005-02-18 |
2013-03-06 |
阿斯利康(瑞典)有限公司 |
抗菌哌啶衍生物
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
GB0510141D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
CA2608014A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Addex Pharma Sa |
Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
|
GB0510142D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
GB0510139D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
US8541457B2
(en)
|
2005-06-03 |
2013-09-24 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
|
US20090221644A1
(en)
*
|
2005-06-30 |
2009-09-03 |
Stuart Edward Bradley |
Gpcr Agonists
|
EP1907383A1
(de)
*
|
2005-06-30 |
2008-04-09 |
Prosidion Limited |
Gpcr-agonisten
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
HUE025466T2
(en)
|
2005-07-26 |
2016-02-29 |
Bial-Portela & Ca S A |
Nitro-pyrocatechin derivatives as comt inhibitors
|
TW200800946A
(en)
*
|
2005-08-15 |
2008-01-01 |
Astrazeneca Ab |
Substituted piperazines as metabotropic glutamate receptor antagonists
|
HUP0500920A2
(en)
*
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Oxadiazole derivatives, process for their preparation and their use
|
BRPI0619282B8
(pt)
|
2005-10-25 |
2021-05-25 |
Kalypsys Inc |
sal, e composição farmacêutica
|
SI1945632T1
(sl)
|
2005-11-08 |
2014-03-31 |
Vertex Pharmaceuticals Incorporated |
Heterocikliäśni modulatorji za prenaĺ alce z atp-vezavno kaseto
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
DE102005062990A1
(de)
*
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
DE102005062991A1
(de)
*
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
TW200800898A
(en)
*
|
2006-02-07 |
2008-01-01 |
Wyeth Corp |
11-Beta HSD1 inhibitors
|
US7951824B2
(en)
*
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
JP5249919B2
(ja)
*
|
2006-03-29 |
2013-07-31 |
エフ.ホフマン−ラ ロシュ アーゲー |
mGluR2アンタゴニストとしてのピリジン及びピリミジン誘導体
|
WO2007110449A1
(en)
|
2006-03-29 |
2007-10-04 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use
|
EP1845097A1
(de)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazolderivate als COMT Inihibitoren
|
TW200815353A
(en)
|
2006-04-13 |
2008-04-01 |
Euro Celtique Sa |
Benzenesulfonamide compounds and their use
|
US8937181B2
(en)
|
2006-04-13 |
2015-01-20 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
TW200811157A
(en)
|
2006-05-05 |
2008-03-01 |
Astrazeneca Ab |
mGluR5 modulators I
|
TW200811156A
(en)
*
|
2006-05-05 |
2008-03-01 |
Astrazeneca Ab |
mGluR5 modulators IV
|
US7943622B2
(en)
|
2006-06-06 |
2011-05-17 |
Cornerstone Therapeutics, Inc. |
Piperazines, pharmaceutical compositions and methods of use thereof
|
FR2903405B1
(fr)
|
2006-07-04 |
2011-09-09 |
Pasteur Institut |
Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
|
AU2007288245A1
(en)
|
2006-08-24 |
2008-02-28 |
Novartis Ag |
2- (pyrazin-2-yl) -thiazole and 2- (1h-pyrazol-3-yl) -thiazole derivatives as well as related compounds as stearoyl-CoA desaturase (SCD) inhibitors for the treatment of metabolic, cardiovascular and other disorders
|
CA2662574A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
AP2780A
(en)
|
2006-10-18 |
2013-09-30 |
Pfizer Prod Inc |
Biaryl ether urea compounds
|
GB0622202D0
(en)
*
|
2006-11-07 |
2006-12-20 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
EA200900820A1
(ru)
|
2006-12-20 |
2010-02-26 |
Новартис Аг |
2-замещенные 5-членные гетероциклы в качестве ингибиторов стеароил-соа-десатуразы (ссд)
|
WO2008091863A1
(en)
|
2007-01-23 |
2008-07-31 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|
KR101522157B1
(ko)
|
2007-01-31 |
2015-05-28 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
Comt 억제제의 투약 방법
|
WO2008124118A1
(en)
|
2007-04-09 |
2008-10-16 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use therof
|
EP2164840A2
(de)
|
2007-05-09 |
2010-03-24 |
Vertex Pharmaceuticals Incorporated |
Modulatoren von cftr
|
US8853392B2
(en)
|
2007-06-03 |
2014-10-07 |
Vanderbilt University |
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
CA2689282A1
(en)
*
|
2007-06-03 |
2008-12-11 |
Vanderbilt University |
Benzamide mglur5 positive allosteric modulators and methods of making and using same
|
CN101801954B
(zh)
|
2007-09-20 |
2013-10-09 |
Irm责任有限公司 |
作为gpr119活性调节剂的化合物和组合物
|
MX2010003002A
(es)
|
2007-09-26 |
2010-07-05 |
Sinai School Medicine |
Analogos de azacitidina y sus usos.
|
US8765736B2
(en)
|
2007-09-28 |
2014-07-01 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
CN101981010A
(zh)
*
|
2007-10-10 |
2011-02-23 |
武田药品工业株式会社 |
酰胺化合物
|
SI2207775T1
(sl)
|
2007-11-05 |
2012-05-31 |
Novartis Ag |
benzilamino karboksiacil piperidinski derivati kot inhibitorji CETP uporabni za zdravljenje bolezni kot je hiperlipidemija ali arterioskleroza
|
CA2707651A1
(en)
|
2007-12-03 |
2009-06-11 |
Novartis Ag |
1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
|
MX2010006179A
(es)
|
2007-12-07 |
2010-08-04 |
Vertex Pharma |
Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
|
EA201070700A1
(ru)
|
2007-12-07 |
2011-06-30 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы получения циклоалкилкарбоксамидопиридинбензойных кислот
|
EP2254879A4
(de)
*
|
2007-12-18 |
2012-10-31 |
Glenmark Pharmaceuticals Sa |
Chroman-derivate als trpv3-modulatoren
|
NZ720282A
(en)
|
2008-02-28 |
2017-12-22 |
Vertex Pharma |
Heteroaryl derivatives as cftr modulators
|
MX2010009043A
(es)
*
|
2008-02-28 |
2010-10-25 |
Bial Portela & Ca Sa |
Composicion farmaceutica para farmacos poco solubles.
|
WO2009116882A1
(en)
|
2008-03-17 |
2009-09-24 |
Portela & Ca., S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
WO2010004379A2
(en)
*
|
2008-06-17 |
2010-01-14 |
Glenmark Pharmaceuticals S.A. |
Chromane derivatives as trpv3 modulators
|
TWI434842B
(zh)
|
2008-07-14 |
2014-04-21 |
Astellas Pharma Inc |
Azole compounds
|
GB0813142D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
GB0813144D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
US8609696B2
(en)
|
2008-12-18 |
2013-12-17 |
Boehringer Ingelheim International Gmbh |
Serotonin 5-HT2B receptor inhibitors
|
PL2381778T3
(pl)
*
|
2008-12-22 |
2017-01-31 |
Chemocentryx, Inc. |
Antagoniści c5ar
|
WO2010096371A2
(en)
*
|
2009-02-18 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds which modulate the cb2 receptor
|
TW201035088A
(en)
|
2009-02-27 |
2010-10-01 |
Supergen Inc |
Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
|
BRPI1016132B8
(pt)
*
|
2009-04-01 |
2021-05-25 |
Bial Portela & Ca Sa |
composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável
|
ES2730678T3
(es)
|
2009-04-01 |
2019-11-12 |
Bial Portela & Ca Sa |
Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para fabricarlas
|
PL2413933T5
(pl)
*
|
2009-04-02 |
2021-10-18 |
Colucid Pharmaceuticals, Inc. |
2,4,6-trifluoro-N-[6-(1-metylopiperydyno-4-karbonylo)pirydyn-2-ylo]benzamid do leczenia migreny drogą doustną lub dożylną
|
CA2758731A1
(en)
*
|
2009-04-23 |
2010-10-28 |
Merck Sharp & Dohme Corp. |
2-alkyl piperidine mglur5 receptor modulators
|
US8673920B2
(en)
|
2009-05-06 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
CN102548986A
(zh)
|
2009-06-05 |
2012-07-04 |
链接医药公司 |
氨基吡咯烷酮衍生物及其用途
|
TW201044234A
(en)
*
|
2009-06-08 |
2010-12-16 |
Chunghwa Picture Tubes Ltd |
Method of scanning touch panel
|
US20120252792A1
(en)
*
|
2009-09-17 |
2012-10-04 |
The Regents Of The University Of Michigan |
Methods and compositions for modulating rho-mediated gene transcription
|
US8389536B2
(en)
*
|
2009-10-27 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Positive allosteric modulators (PAM)
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
US8586581B2
(en)
|
2009-12-17 |
2013-11-19 |
Hoffmann-La Roche Inc |
Ethynyl compounds useful for treatment of CNS disorders
|
US8772301B2
(en)
|
2009-12-18 |
2014-07-08 |
Sunovion Pharmaceuticals, Inc. |
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
|
JP2013517271A
(ja)
|
2010-01-15 |
2013-05-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節する化合物
|
CA2795062A1
(en)
|
2010-04-02 |
2011-10-06 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
|
EP2555755B2
(de)
|
2010-04-07 |
2019-07-10 |
Vertex Pharmaceuticals Incorporated |
Pharmazeutische zusammensetzungen von 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-yl)-cyclopropancarboxamido)-3-methylpyridin-2-yl)benzoesäure und ihre verabreichung
|
US8420661B2
(en)
|
2010-04-13 |
2013-04-16 |
Hoffmann-La Roche Inc. |
Arylethynyl derivatives
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
WO2011140190A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Tetrazolones as inhibitors of fatty acid synthase
|
KR20130087002A
(ko)
|
2010-06-04 |
2013-08-05 |
알바니 몰레큘라 리써치, 인크. |
글리신 수송체-1 저해제, 그의 제조 방법 및 그의 용도
|
JP2013529647A
(ja)
|
2010-06-24 |
2013-07-22 |
ケモセントリックス,インコーポレイティド |
C5aRアンタゴニスト
|
US8846936B2
(en)
|
2010-07-22 |
2014-09-30 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the CB2 receptor
|
US20130210804A1
(en)
*
|
2010-10-25 |
2013-08-15 |
Neville J. Anthony |
Tricyclic mglur5 receptor modulators
|
EP2632465B1
(de)
|
2010-10-27 |
2015-12-30 |
Merck Sharp & Dohme Corp. |
Inhibitoren des renalen kaliumkanals der äusseren medulla
|
US9056859B2
(en)
|
2010-10-29 |
2015-06-16 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
US8772300B2
(en)
|
2011-04-19 |
2014-07-08 |
Hoffmann-La Roche Inc. |
Phenyl or pyridinyl-ethynyl derivatives
|
MX337443B
(es)
|
2011-04-26 |
2016-03-07 |
Hoffmann La Roche |
Derivados de etinilo como moduladores alostericos positivos del receptor de glutamato metabotropico del subtipo 5 (mglur5).
|
EP2702050B1
(de)
|
2011-04-26 |
2016-05-18 |
F.Hoffmann-La Roche Ag |
Pyrazolidin-3-on-derivate
|
MX2014001732A
(es)
|
2011-08-15 |
2014-07-09 |
Intermune Inc |
Antagonistas del receptor de acido lisofosfatidico.
|
RU2014110401A
(ru)
|
2011-08-19 |
2015-09-27 |
Мерк Шарп И Доум Корп. |
Ингибиторы внешнего медуллярного калиевого канала почек
|
UY34305A
(es)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
|
EP2755656B1
(de)
|
2011-09-16 |
2016-09-07 |
Merck Sharp & Dohme Corp. |
Inhibitoren des renalen kaliumkanals der äusseren medulla
|
US20130123254A1
(en)
|
2011-09-30 |
2013-05-16 |
Barbara Biemans |
Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification
|
US9926309B2
(en)
|
2011-10-05 |
2018-03-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
WO2013052845A1
(en)
|
2011-10-05 |
2013-04-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
UA110995C2
(uk)
|
2011-10-07 |
2016-03-10 |
Ф. Хоффманн-Ля Рош Аг |
Етинільні похідні як модулятори метаботропного глутаматного рецептора
|
UA110862C2
(uk)
|
2011-10-07 |
2016-02-25 |
Ф. Хоффманн-Ля Рош Аг |
Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5
|
EP2771005B1
(de)
|
2011-10-25 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
Inhibitoren des renalen kaliumkanals der äusseren medulla
|
US8940898B2
(en)
|
2011-10-25 |
2015-01-27 |
Merck Sharp & Dohme Corp. |
Piperidinyl alkyne orexin receptor antagonists
|
WO2013062900A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
WO2013066718A2
(en)
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US9139585B2
(en)
|
2011-10-31 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Inhibitors of the Renal Outer Medullary Potassium channel
|
US9108947B2
(en)
|
2011-10-31 |
2015-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the Renal Outer Medullary Potassium channel
|
US9126988B2
(en)
|
2011-12-13 |
2015-09-08 |
Bial—Portela & Ca, S.A. |
Intermediate for preparing a catechol-O-methyltransferase inhibitor
|
WO2013090271A1
(en)
|
2011-12-16 |
2013-06-20 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
KR20190007106A
(ko)
|
2011-12-21 |
2019-01-21 |
노비라 테라퓨틱스, 인코포레이티드 |
B형 간염의 항바이러스성 제제
|
ES2632237T3
(es)
|
2012-02-02 |
2017-09-12 |
Idorsia Pharmaceuticals Ltd |
Compuestos de 4-(benzoimidazol-2-il)-tiazol y derivados aza relacionados
|
TWI570120B
(zh)
|
2012-06-04 |
2017-02-11 |
艾克泰聯製藥有限公司 |
苯并咪唑脯胺酸衍生物
|
NZ701849A
(en)
|
2012-07-17 |
2016-07-29 |
Hoffmann La Roche |
Arylethynyl derivatives
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
UA113223C2
(xx)
|
2012-08-13 |
2016-12-26 |
|
Арилетинілпіримідини
|
BR112015004205B1
(pt)
|
2012-08-28 |
2022-02-01 |
Janssen Sciences Ireland Uc |
Sulfamoil-arilamidas, seu uso das mesmas como medicamentos para o tratamento da hepatite b, composição farmacêutica que as compreende e produto
|
NZ706283A
(en)
|
2012-09-27 |
2018-07-27 |
Hoffmann La Roche |
Arylethynyl derivatives
|
CA2885180C
(en)
|
2012-10-10 |
2021-03-02 |
Actelion Pharmaceuticals Ltd |
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
|
EP2925322B1
(de)
|
2012-11-29 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Inhibitoren des renalen kaliumkanals der äusseren medulla
|
UA115156C2
(uk)
|
2012-12-11 |
2017-09-25 |
Такеда Фармасьютікал Компані Лімітед |
Гетероциклічна сполука
|
WO2014099633A2
(en)
|
2012-12-19 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
EP2956142B1
(de)
|
2013-02-18 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
Inhibitoren des renalen kaliumkanals der äusseren medulla
|
SI2961732T1
(sl)
|
2013-02-28 |
2017-07-31 |
Janssen Sciences Ireland Uc |
Sulfamoil-arilamidi in njihova uporaba kot zdravila za zdravljenje hepatitisa B
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
CN105051040A
(zh)
|
2013-03-12 |
2015-11-11 |
埃科特莱茵药品有限公司 |
作为食欲素受体拮抗剂的氮杂环丁烷酰胺衍生物
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
US9765074B2
(en)
|
2013-03-15 |
2017-09-19 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
EP2981536B1
(de)
|
2013-04-03 |
2017-06-14 |
Janssen Sciences Ireland UC |
N-pehnyl-carboxamid-derivate und verwendung davon als medikamente zur behandlung von hepatitis b
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
EP2803668A1
(de)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole
|
US10259807B2
(en)
|
2013-07-22 |
2019-04-16 |
Idorsia Pharmaceuticals Ltd. |
1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
|
DK3024819T3
(en)
|
2013-07-25 |
2018-06-06 |
Janssen Sciences Ireland Uc |
GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
|
US9751881B2
(en)
|
2013-07-31 |
2017-09-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
WO2015018027A1
(en)
*
|
2013-08-08 |
2015-02-12 |
Merck Sharp & Dohme Corp. |
Thiazole orexin receptor antagonists
|
RU2671496C2
(ru)
|
2013-10-14 |
2018-11-01 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Производные 5-пиперидин-8-цианохинолина
|
RS59911B1
(sr)
|
2013-10-14 |
2020-03-31 |
Eisai R&D Man Co Ltd |
Selektivno supstituisana jedinjenja hinolina
|
WO2015059212A1
(en)
|
2013-10-23 |
2015-04-30 |
Janssen R&D Ireland |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
HUE054389T2
(hu)
|
2013-11-12 |
2021-09-28 |
Vertex Pharma |
Eljárás CFTR-mediálta betegségek kezelésére szolgáló gyógyászati kompozíciók elõállítására
|
CN105873921B
(zh)
|
2013-12-04 |
2019-03-15 |
爱杜西亚药品有限公司 |
苯并咪唑-脯氨酸衍生物的用途
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US10392349B2
(en)
|
2014-01-16 |
2019-08-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US20150216938A1
(en)
|
2014-02-05 |
2015-08-06 |
Novira Therapeutics Inc. |
Combination therapy for treatment of hbv infections
|
EA035848B1
(ru)
|
2014-02-06 |
2020-08-20 |
Янссен Сайенсиз Айрлэнд Юси |
Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
KR20170031668A
(ko)
|
2014-06-02 |
2017-03-21 |
칠드런'즈 메디컬 센터 코포레이션 |
면역 조절을 위한 방법 및 조성물
|
WO2016053890A1
(en)
|
2014-09-29 |
2016-04-07 |
Chemocentryx, Inc. |
PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS
|
WO2016065585A1
(en)
*
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Piperidine isoxazole and isothiazole orexin receptor antagonists
|
WO2016065584A1
(en)
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Piperidine oxadiazole and thiadiazole orexin receptor antagonists
|
WO2016065586A1
(en)
*
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Pyrazole, triazole and tetrazole orexin receptor antagonists
|
HUE055423T2
(hu)
|
2014-11-18 |
2021-11-29 |
Vertex Pharma |
Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
EA032927B1
(ru)
|
2015-01-15 |
2019-08-30 |
Идорсия Фармасьютиклз Лтд |
Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
|
WO2016127358A1
(en)
|
2015-02-12 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of renal outer medullary potassium channel
|
EA201792069A1
(ru)
|
2015-03-19 |
2018-04-30 |
Новира Терапьютикс, Инк. |
Производные азокана и азонана и способы лечения инфекций гепатита в
|
DK3286176T3
(da)
*
|
2015-04-24 |
2020-03-02 |
Pfizer |
Krystallinske former af 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)ureamaleat
|
EP3303316B1
(de)
|
2015-06-03 |
2020-01-29 |
H. Hoffnabb-La Roche Ag |
Ethynylderivate
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
CN106349228B
(zh)
|
2015-07-17 |
2019-07-09 |
广东东阳光药业有限公司 |
取代的喹唑啉酮类化合物及其制备方法和用途
|
CA3000197A1
(en)
|
2015-09-29 |
2017-04-06 |
Novira Therapeutics, Inc. |
Crystalline forms of a hepatitis b antiviral agent
|
TWI791423B
(zh)
|
2016-01-14 |
2023-02-11 |
美商卡默森屈有限公司 |
C3腎絲球病變之治療方法
|
WO2017147526A1
(en)
|
2016-02-26 |
2017-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
JP2019511542A
(ja)
|
2016-04-15 |
2019-04-25 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
カプシド集合阻害剤を含む組み合わせ及び方法
|
EP3464272B1
(de)
|
2016-06-07 |
2021-12-08 |
Jacobio Pharmaceuticals Co., Ltd. |
Neuartige, als shp2-inhibitoren nützliche heterocyclische derivate
|
EP3375778A1
(de)
|
2017-03-14 |
2018-09-19 |
Artax Biopharma Inc. |
Aryl-piperidinderivate
|
AU2018239542C1
(en)
|
2017-03-23 |
2021-02-11 |
Jacobio Pharmaceuticals Co., Ltd. |
Novel heterocyclic derivatives useful as SHP2 inhibitors
|
US11440922B2
(en)
*
|
2017-06-29 |
2022-09-13 |
Recordati Industria Chimica e Farmacentica S.p.A. |
Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors
|
KR102656934B1
(ko)
|
2017-07-10 |
2024-04-16 |
셀진 코포레이션 |
항증식성 화합물 및 이의 사용 방법
|
MX2020003671A
(es)
|
2017-10-06 |
2020-08-03 |
Forma Therapeutics Inc |
Inhibicion de peptidasa especifica de ubiquitina 30.
|
BR112020016466A2
(pt)
|
2018-02-13 |
2020-12-15 |
Gilead Sciences, Inc. |
Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1, para tratar câncer e para aprimorar a função de células-t em pacientes com hepatite b crônica (chb), e, kit para tratar ou prevenir câncer ou uma doença ou condição.
|
MX2020009531A
(es)
|
2018-03-14 |
2020-10-05 |
Janssen Sciences Ireland Unlimited Co |
Regimen posologico del modulador del ensamblaje de la capside.
|
US10899735B2
(en)
|
2018-04-19 |
2021-01-26 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
CA3103286C
(en)
|
2018-07-13 |
2023-05-09 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
LT3860989T
(lt)
|
2018-10-05 |
2023-06-12 |
Forma Therapeutics, Inc. |
Sulieti pirolinai, kurie veikia kaip ubikvitinui specifinės proteazės 30 (ups30) inhibitoriai
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
AU2019366355B2
(en)
|
2018-10-24 |
2022-10-13 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
EP3886854A4
(de)
|
2018-11-30 |
2022-07-06 |
Nuvation Bio Inc. |
Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung
|
WO2020154431A1
(en)
*
|
2019-01-25 |
2020-07-30 |
Lynch Kevin R |
Inhibitors of spinster homolog 2 (spns2) for use in therapy
|
AU2020223865A1
(en)
|
2019-02-22 |
2021-07-15 |
Janssen Sciences Ireland Unlimited Company |
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
|
JP2022532526A
(ja)
|
2019-05-06 |
2022-07-15 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
Hbv感染又はhbv誘導性疾患の処置において有用なアミド誘導体
|
TWI776175B
(zh)
|
2019-07-09 |
2022-09-01 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體,以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
US11091447B2
(en)
|
2020-01-03 |
2021-08-17 |
Berg Llc |
UBE2K modulators and methods for their use
|
US20230373937A1
(en)
*
|
2020-09-09 |
2023-11-23 |
University Of Virginia Patent Foundation |
Inhibitors of spinster homolog 2 (spns2) for use in therapy
|
WO2022069953A1
(en)
*
|
2020-09-29 |
2022-04-07 |
Ranjith Siddaraj |
Synthesis and characterization of (s)-3-(5- fluoropyridin-2-yl)-5-(piperidin-3-yl)-l,2,4-oxadiazole derivatives and their secretory phospholipase a2 (spla2) inhibitor activity
|
UY39800A
(es)
|
2021-06-04 |
2023-01-31 |
Vertex Pharma |
N–(hidroxialquil (hetero)aril) tetrahidrofuran carboxamidas como moduladores de canales de sodio
|
WO2023288046A1
(en)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions and methods relating to cells with adhered particles
|